ArticleEnvironment & health (Washington, D.C.)2026
AI-Enabled Mapping of Structure-Hazard Relationships for Emerging Contaminants.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging contaminant hazards are widespread, yet evidence is fragmented across the literature, registries, inventories, and bioassays. This study presents an integrated, reproducible framework that aligns literature-derived signals with molecular structure and regulatory hazard dimensions within a persistence, bioaccumulation, mobility, and toxicity (PBMT) lens. A task-tuned large language model extracted 21,277 mentions from 9,557 publications; harmonization across CompTox, PubChem, and Wikipedia yielded 1,081 unique candidates with 94.6% name consistency against 17 inventories. The landscape shows abundant toxicity information but limited mobility data. Structure profiling identified a recurring motifan aromatic core with branched alkyl substituents and oxygenated groupsand directional associations with composite hazard (positive for halogenation and negative for several oxygenated groups). To extend pathway inference to list-naïve chemicals, AutoGluon models trained on Tox21/ToxCast were applied to 49 additional candidates. This produced end-point-level predictions concentrated at the protein-function level (receptors, enzymes, transcription factors), which is operationally useful for prioritization. Combining model scores with PBMT evidence density yielded an auditable prioritization, highlighting where mobility measurements and focused assays would most increase confidence. The framework links textual, structural, regulatory, and predictive streams to enable rapid screening, targeted data acquisition, safer substitution, and adaptive regulatory updating.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.